Diagnostic Value of Confocal Laser Endomicroscopy (CelTouch) for Peripheral Lung Lesions
1 other identifier
observational
286
1 country
1
Brief Summary
This study uses CelTouch to explore patients with lung lesions scheduled for lung biopsy. By comparing with preclinical CLE images and pathological images, CLE diagnostic criteria for benign and malignant lung lesions under the microscope will be established; the performance of CLE in diagnosing peripheral lung lesions will be validated through multicenter clinical research; and a CLE atlas for peripheral lung lesions will be constructed to establish a visual classification diagnostic system for peripheral lung lesions. (1) Comparative Study of In Vivo CLE Images and Pathological Images in the Diagnosis of Peripheral Lung Lesions
- 1.Collect CLE images and histopathological sections of clearly diagnosed peripheral lung lesions.
- 2.A diagnostic team composed of 1 bronchoscopy expert, 1 pathology expert, and 2 CLE experts will correlate in vivo and ex vivo CLE images of lung lesions with corresponding pathological images, analyze CLE image characteristics of benign and malignant lung lesions, and establish CLE diagnostic criteria for benign and malignant lung lesions.
- 3.Multicenter screening of corresponding subjects according to inclusion and exclusion criteria, collection of corresponding videos and images during surgery, and recording of observed characteristic images based on pre-established diagnostic characteristics and criteria.
- 4.The diagnostic team and sub-center representatives (5 in total) will perform offline interpretation of the collected images and videos, and evaluate the diagnostic performance of CLE in peripheral lung lesions using the accurate diagnostic results obtained from postoperative histopathology or 6-month clinical follow-up as the standard.
- 5.Establishment of a CLE Atlas and Classification System for Lung Lesions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2025
CompletedStudy Start
First participant enrolled
May 31, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 4, 2025
May 1, 2025
1 year
May 26, 2025
May 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic yield
diagnostic yield=(The number of cases with a definitive diagnosis / The total number of cases enrolled in the trial) × 100%
6 months after procedure
Study Arms (1)
Confocal laser endomicroscopy group
Utilize confocal laser endomicroscopy for the examination of peripheral lung lesions in patients.
Eligibility Criteria
1. All subjects have completed CelTouch examination 2. Each subject has obtained a clear histological diagnosis or clinical follow-up diagnosis for 6 months
You may qualify if:
- Aged ≥18 years, with lung lesions detected by chest CT and scheduled for lung biopsy;
- Preoperative CT indicates the presence of a bronchus leading to the lesion to be biopsied;
- Able to understand and willing to sign a written informed consent form. -
You may not qualify if:
- Those with contraindications to general anesthesia or bronchoscopy;
- Patients with uncorrectable coagulation disorders;
- Unable to discontinue therapeutic anticoagulants within an appropriate time interval before surgery;
- Patients with severe liver or kidney dysfunction, cardiovascular and cerebrovascular diseases, mental illnesses, etc.;
- Pregnant or lactating patients;
- Those without a clear histological or clinical diagnosis;
- Subjects deemed unsuitable by the investigator. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163
Guangzhou, Guangdong, 510100, China
Related Publications (1)
Wijmans L, Yared J, de Bruin DM, Meijer SL, Baas P, Bonta PI, Annema JT. Needle-based confocal laser endomicroscopy for real-time diagnosing and staging of lung cancer. Eur Respir J. 2019 Jun 20;53(6):1801520. doi: 10.1183/13993003.01520-2018. Print 2019 Jun.
PMID: 31023849BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 26, 2025
First Posted
June 4, 2025
Study Start
May 31, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share